Form DRS - Draft Registration Statement:
SEC Accession No. 0001641172-25-016944
Filing Date
2025-06-27
Accepted
2025-06-27 17:02:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1263571
2 filename2.htm EX-5.1 13203
3 GRAPHIC formdrs_001.jpg GRAPHIC 15567
4 GRAPHIC ex5-1_001.jpg GRAPHIC 10144
  Complete submission text file 0001641172-25-016944.txt   1313651
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-08149 | Film No.: 251087509
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)